Immediate Impact

1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
2023 Standout
Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
2 intermediate papers

Works of J. Mould being referenced

Randomized Trial Comparing Aminoglutethimide With High-Dose Medroxyprogesterone Acetate in Therapy for Advanced Breast Carcinomau
1988
Phase II study of ifosfamide in cervical cancer.
1986

Author Peers

Author Last Decade Papers Cites
J. Mould 215 180 166 27 439
Wayne A. Christopherson 201 117 199 24 466
Anne Lesoin 236 176 294 40 507
Piver Ms 130 117 225 44 442
G Deppe 103 176 179 27 384
Summer Dewdney 183 121 162 35 435
John A. Jefferies 137 105 179 18 424
Jacob M. Estes 110 199 203 35 508
G Putignano 173 120 124 25 408
Jason Yap 290 107 231 33 497
Kate J. Krause 105 131 90 35 483

All Works

Loading papers...

Rankless by CCL
2026